Cello Therapeutics, Inc.

Nanotechnology ResearchCalifornia, United States2-10 Employees

Cello Therapeutics, Inc. is a small biotechnology company based in San Diego, California, focused on nanotechnology for cancer therapy. It develops nanoparticles that carry FDA-approved anticancer drugs inside a biocompatible polymer core. The particles are cloaked with a membrane derived from red blood cells, a design intended to reduce immune recognition and extend circulation to improve delivery to tumors. The company licenses its nanoparticle technology and lab protocols from its parent, Arytha Biosciences, and benefits from the membrane-coating expertise of its sister company Cellics Therapeutics, which also works on biodetoxification and infectious-disease applications. Founded in 2016, Cello Therapeutics is presently in the drug development and testing stage.

Sign up for free to view info

Email Format Employee directory